10-22-2009, 12:08 PM
|
 |
Moderator
|
|
Join Date: Feb 2008
Posts: 724
|
|
Re: Everything You Need to Know About Specialty Pipeline between 10/2009 to 3/2010
Here are 2 recently approved drugs that were not included in this forecast: Votrient (pazopanib) and Prolastin-C (Alpha1-Proteinase Inhibitor [Human] (see: FDA update on brand drugs for October 22, 2009) |